What we know and don’t know about the bioeffects of nanoparticles: developing experimental approaches for safety assessment

Author： Stratmeyer Mel   Goering Peter   Hitchins Victoria   Umbreit Thomas  

Publisher： Springer Publishing Company

ISSN： 1387-2176

Source： Biomedical Microdevices, Vol.12, Iss.4, 2010-08, pp. : 569-573

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Developing and Deploying a Patient Safety Program in a Large Health Care Delivery System: You Can't Fix What You Don't Know About

By Bagian James P.   Lee Caryl   Gosbee John   DeRosier Joseph   Stalhandske Erik   Eldridge Noel   Williams Rodney   Burkhardt Mary  

Joint Commission Journal on Quality and Patient Safety, Vol. 27, Iss. 10, 2001-10 ,pp. : 522-532

Joint Commission Resources

Access to resources Recommend Favorite

What we know (and don't know) about the biology and functions of mast cells and basophils

By  

IMMUNOLOGICAL REVIEWS (ELECTRONIC), Vol. 282, Iss. 1, 2018-03 ,pp. : 5-7

John Wiley & Sons Inc

Access to resources Recommend Favorite

What we don't know about the Brain and Hypnosis, but need to: A View from the Buckhorn Inn

By Woody Erik Z.   McConkey Kevin M.  

International Journal of Clinical and Experimental Hypnosis, Vol. 51, Iss. 3, 2003-07 ,pp. : 309-338

Routledge Ltd

Access to resources Recommend Favorite

Don't know much about embryology...

By  

Canadian Journal of Emergency Medicine, Vol. 17, Iss. 2, 2015-03 ,pp. : 196-198

Cambridge University Press

Access to resources Recommend Favorite

What do we know about the safety of corticosteroids in rheumatoid arthritis?

By Ethgen Olivier   de Lemos Esteves Frédéric   Bruyere Olivier   Reginster Jean-Yves  

Current Medical Research and Opinion, Vol. 29, Iss. 9, 2013-09 ,pp. : 1147-1160

Informa Healthcare

Access to resources Recommend Favorite